Group 1 - Shanghai is focusing on creating a long-term, stable, transparent, and predictable development environment to provide new opportunities for global enterprises [2] - The "14th Five-Year Plan" emphasizes high-level opening up and prioritizes technological innovation, aiming for high-quality development in Shanghai [2] - The biopharmaceutical industry is one of the three key leading industries in Shanghai, with a call for increased innovation and collaboration in drug development from global leaders like Boehringer Ingelheim [2] Group 2 - Zeiss, a leading manufacturer of optical and optoelectronic equipment, is encouraged to enhance its regional headquarters functions and increase R&D and manufacturing presence in Shanghai [2] - Both companies expressed commitment to deepening innovation and collaboration in the Chinese market, with Boehringer Ingelheim focusing on human pharmaceuticals and animal health [4] - Zeiss highlighted the importance of Shanghai's business environment and strategic development plans, reinforcing its investment confidence in the region [4]
陈吉宁分别会见勃林格殷格翰股东委员会主席冯保和、蔡司集团总裁兼首席执行官裴安德
Di Yi Cai Jing·2026-02-09 00:22